These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38078739)

  • 1. Response to tibial and sacral nerve modulation in overactive bladder: Is there any correlation?
    Fourel M; Hafez S; Ramdane N; Perrouin-Verbe MA; De Wachter S; Vermersch P; Biardeau X
    Neurourol Urodyn; 2024 Feb; 43(2):415-423. PubMed ID: 38078739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial.
    Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E
    Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
    Kapur A; Aalami Harandi A; Hartman-Kenzler J; Kim J
    Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial.
    Teixeira Alve A; Azevedo Garcia P; Henriques Jácomo R; Batista de Sousa J; Borges Gullo Ramos Pereira L; Barbaresco Gomide Mateus L; Gomes de Oliveira Karnikoskwi M
    Maturitas; 2020 May; 135():40-46. PubMed ID: 32252963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-management of overactive bladder at home using transcutaneous tibial nerve stimulation: a qualitative study of women's experiences.
    Daly CME; Loi L; Booth J; Saidan D; Guerrero K; Tyagi V
    BMC Womens Health; 2021 Oct; 21(1):374. PubMed ID: 34706709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial.
    Alkis O; Sevim M; Güven Kartal İ; Baser A; İbrahim İvelik H; Aras B
    Int J Clin Pract; 2021 Sep; 75(9):e14342. PubMed ID: 33966335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review.
    Sayner AM; Rogers F; Tran J; Jovanovic E; Henningham L; Nahon I
    Neuromodulation; 2022 Dec; 25(8):1086-1096. PubMed ID: 35688702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
    Tu H; Li N; Liu W; Fan Z; Kong D
    PLoS One; 2022; 17(7):e0269371. PubMed ID: 35901036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder.
    Polat Dunya C; Tülek Z; Kürtüncü M; Gündüz T; Panicker JN; Eraksoy M
    Neurourol Urodyn; 2021 Aug; 40(6):1661-1669. PubMed ID: 34174117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis.
    Zonić-Imamović M; Imamović S; Čičkušić A; Delalić A; Hodžić R; Imamović M
    Acta Med Acad; 2019 Dec; 48(3):271-277. PubMed ID: 32124625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous tibial nerve stimulation in patients with multiple sclerosis and overactive bladder: a real-life clinical and urodynamic assessment.
    Hentzen C; Chesnel C; Lagnau P; Blouet E; Teng M; Amarenco G
    World J Urol; 2024 Mar; 42(1):136. PubMed ID: 38478090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.